LEGN

Legend Biotech Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$18.54

Price (1 Year)

$35.87 $16.8

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %3.6 / %30
Non-compliant assets / Total market cap %0.5 / %30
Non-compliant revenue / Total income %3.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM).

Website

Analysis (Turkish): LEGN Hissesi Caiz mi, Helal mi? Legend Biotech Corporation Katılım Analizi